Company Securities Exchange Announcements
2021 ASX Announcements
Notice of Annual General Meeting/ Proxy Form (16/11/21)
US DoD Travelan Clinical Update (15/11/21)
Jobkeeper Payment Notification (11/11/21)
US DoD Naval Medical Research Center Clinical Update (10/11/21)
Notification regarding unquoted securities - IMC (5/11/21)
Application for quotation of securities - IMC (5/11/21)
Immuron filed XBRL data with the SEC (3/11/21)
Form 20-F filed with the SEC (29/10/21)
Amended Appendix 3H (27/10/21)
Notification of cessation of securities - IMC (26/10/21)
Change in substantial holding (20/10/21)
Change in substantial holding (15/10/21)
IMM124E Demonstrates Antiviral T-Cell Immunity (8/10/21)
Corporate Governance Statement (30/09/21)
Annual Report to Shareholders (30/09/21)
Director Resignation - Peter Anastasiou (24/09/21)
Reinstatement to Official Quotation (23/9/21)
Immuron Planned Acquisition of R&D Vaccine Company (23/9/21)
Preliminary Final Report (31/08/21)
Change in Substantial Holding (3/06/21)
Suspension from Official Quotation (31/05/21)
Change in Substantial Holding (20/05/21)
IMM124E May Offer New Modality for Inhibition of SARS-CoV-2 (13/05/21)
Half Yearly Reports and Accounts (25/02/21)
Change of Director's Notice (9/02/21)
